"Today, we're proud to announce an important update to our label ... Sanofi's largest flu vaccine safety studies ever done in pregnant individuals, an important at-risk population group for influenza.

The FDA has approved Sanofi Pasteur's supplemental biologics license application (sBLA) for licensure of its four-strain influenza vaccine ... associated with its off-label use.

"Today, we're proud to announce an important update to our label for FLUBLOK, from one of Sanofi's largest flu vaccine safety studies ever done in pregnant individuals, an important at-risk population ...

You have permission to edit this article. Edit Close Activate Subscribe My Account Logout Login/Register ...

BRIDGEWATER, N.J., Oct. 16, 2024 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has updated the label for FLUBLOK (Influenza Vaccine) to include data from a new safety study involving ...

US FLUBLOK label 1 updated to incorporate new safety study in pregnant individuals New safety data involving more than 48,000 pregnant individuals published in American Journal of Obstetrics and ...